282P Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancerOliver Klein, A. Nagrial, Ashray Gunjur et al.|Annals of Oncology|2024Cited by 3
623P Phase II trial of vemurafenib (VEM) and cobimetinib (COB) in BRAF V600-mutated solid tumours and first-line (1L) non-small cell lung cancer (NSCLC): Australian molecular screening and therapeutics (MoST) substudy 12F.P. Lin, David M. Thomas, A. Mersiades et al.|Annals of Oncology|2024Cited by 1